Post-pandemic excess mortality of COVID-19 in Hong Kong: a retrospective studyResearch in context

Summary: Background: As the COVID-19 pandemic shifted into the post-pandemic period in early 2023, following the COVID-19 normalization with relaxation of stringent control measures and high vaccination coverage in Hong Kong, its long-term impact on mortality remains challenging with necessary need...

Full description

Saved in:
Bibliographic Details
Main Authors: Kehang Li, Yuchen Wei, Chi Tim Hung, Carlos King Ho Wong, Xi Xiong, Paul Kay Sheung Chan, Shi Zhao, Zihao Guo, Guozhang Lin, Qiaoge Chi, Carrie Ho Kwan Yam, Tsz Yu Chow, Conglu Li, Xiaoting Jiang, Shuk Yu Leung, Ka Li Kwok, Eng Kiong Yeoh, Ka Chun Chong
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:The Lancet Regional Health. Western Pacific
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666606525000914
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary: Background: As the COVID-19 pandemic shifted into the post-pandemic period in early 2023, following the COVID-19 normalization with relaxation of stringent control measures and high vaccination coverage in Hong Kong, its long-term impact on mortality remains challenging with necessary needs of data-driven insights. This study examined the pattern of post-pandemic excess mortality in Hong Kong. Methods: We analyzed weekly inpatient death data from public hospitals from January 1, 2013, to June 1, 2024, using a mixed model with over-dispersed Poisson regression. Expected mortality was estimated as the difference between observed mortality and baseline derived from pre-pandemic data. Age-stratified analyses of overall and cause-specific mortality were conducted across the pre-Omicron pandemic, Omicron, and post-pandemic periods. Findings: In the post-pandemic period, the excess mortality declined but remained six-fold higher (37.66 [95% CI: 32.72–42.60] per 100,000) than pre-Omicron level, maintaining significance after adjusting for age (32.79 [95% CI: 28.13–37.46] per 100,000). The older population experienced sustained excess mortality, with crude estimates of 100.51 and 586.74 per 100,000 among those aged 65–79 years and ≥80 years, respectively, primarily due to respiratory diseases. Younger population showed near-zero overall excess mortality, whereas increased excess mortality among them occurred in heart disease, cerebrovascular disease, and injuries. Interpretation: Our findings highlight the lasting mortality impact of pandemic among vulnerable populations, specifically the older population, possibly due to the post-COVID conditions and circulating COVID-19, suggesting the need for targeted interventions for this group. Funding: Health and Medical Research Fund.
ISSN:2666-6065